Diabetes Pay-for-Performance Programs and Hepatocellular Carcinoma Risk in Type 2 Diabetes

SSRN Electronic Journal 2026 Preprint Open access

Read full text
Authors: Chaoyi Lai, Cheng-Li Lin, Cong-Tian Wang, Hung‐Wei Wang, Wei‐Fan Hsu, Wen‐Lung Ma, Tzu-Yuan Wang, Cheng-Yuan Peng, Hsueh-Chou Lai
DOI: 10.2139/ssrn.6301902
Cited by: 0

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Metabolism Diabetes and Cancer Primary Care and Health Outcomes

Publication details

Journal / source
SSRN Electronic Journal
Publication date
1 January 2026
Language
EN
Document type
Preprint